Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Nov;47(11):1010–1014. doi: 10.1136/jcp.47.11.1010

Which proliferation markers for routine immunohistology? A comparison of five antibodies.

D S Rose 1, P H Maddox 1, D C Brown 1
PMCID: PMC503063  PMID: 7829674

Abstract

AIMS--To determine the best of five antibodies for immunohistochemical assessment of growth fraction in formalin fixed, paraffin wax embedded tissues. METHODS--Sections from 100 recent, and 17 ten year old or over wax embedded blocks of normal and malignant tissues were immunostained with monoclonal Ki67, polyclonal Ki67, PC10, MIB1, and JC1. The antibodies were evaluated for specificity of nuclear versus cytoplasmic staining, cleanliness of background, and compared with the expected pattern of staining in normal tissues, defined immunohistochemically by monoclonal Ki67 antibody in frozen tissues or by tritiated thymidine uptake. RESULTS--No marker was ideal, but best results were obtained with MIB1 and polyclonal Ki67, followed by JC1, PC10, and monoclonal Ki67. CONCLUSIONS--For routine use, MIB1 or polyclonal Ki67 are the best proliferation markers in conventional histological preparations. The other markers tested cannot be recommended.

Full text

PDF
1010

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bouzubar N., Walker K. J., Griffiths K., Ellis I. O., Elston C. W., Robertson J. F., Blamey R. W., Nicholson R. I. Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer. 1989 Jun;59(6):943–947. doi: 10.1038/bjc.1989.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bravo R., Frank R., Blundell P. A., Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature. 1987 Apr 2;326(6112):515–517. doi: 10.1038/326515a0. [DOI] [PubMed] [Google Scholar]
  3. Bravo R., Macdonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol. 1987 Oct;105(4):1549–1554. doi: 10.1083/jcb.105.4.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown D. C., Gatter K. C. Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma. J Clin Pathol. 1992 Jul;45(7):579–582. doi: 10.1136/jcp.45.7.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown D. C., Gatter K. C. Monoclonal antibody Ki-67: its use in histopathology. Histopathology. 1990 Dec;17(6):489–503. doi: 10.1111/j.1365-2559.1990.tb00788.x. [DOI] [PubMed] [Google Scholar]
  6. Cattoretti G., Becker M. H., Key G., Duchrow M., Schlüter C., Galle J., Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992 Dec;168(4):357–363. doi: 10.1002/path.1711680404. [DOI] [PubMed] [Google Scholar]
  7. Cattoretti G., Pileri S., Parravicini C., Becker M. H., Poggi S., Bifulco C., Key G., D'Amato L., Sabattini E., Feudale E. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol. 1993 Oct;171(2):83–98. doi: 10.1002/path.1711710205. [DOI] [PubMed] [Google Scholar]
  8. Charalambous C., Singh N., Isaacson P. G. Immunohistochemical analysis of Hodgkin's disease using microwave heating. J Clin Pathol. 1993 Dec;46(12):1085–1088. doi: 10.1136/jcp.46.12.1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cross S. S., Start R. D., Smith J. H. Does delay in fixation affect the number of mitotic figures in processed tissue? J Clin Pathol. 1990 Jul;43(7):597–599. doi: 10.1136/jcp.43.7.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cuevas E., Jones D. B., Wright D. H. Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol. 1993 Apr;169(4):477–478. doi: 10.1002/path.1711690415. [DOI] [PubMed] [Google Scholar]
  11. Darnton S. J., Gray M. R., Crocker J. Another cautionary note on the use of PCNA and AgNORs as markers for proliferation. J Pathol. 1992 Sep;168(1):87–87. [PubMed] [Google Scholar]
  12. Egan M. J., Crocker J. Nucleolar organiser regions in pathology. Br J Cancer. 1992 Jan;65(1):1–7. doi: 10.1038/bjc.1992.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ellis P. S., Whitehead R. Mitosis counting--a need for reappraisal. Hum Pathol. 1981 Jan;12(1):3–4. doi: 10.1016/s0046-8177(81)80235-3. [DOI] [PubMed] [Google Scholar]
  14. Garrido M. C., Cordell J. L., Becker M. H., Key G., Gerdes J., Jones M., Gatter K. C., Mason D. Y. Monoclonal antibody JC1: new reagent for studying cell proliferation. J Clin Pathol. 1992 Oct;45(10):860–865. doi: 10.1136/jcp.45.10.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gatter K. C., Dunnill M. S., Gerdes J., Stein H., Mason D. Y. New approach to assessing lung tumours in man. J Clin Pathol. 1986 Jun;39(6):590–593. doi: 10.1136/jcp.39.6.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gentili C., Sanfilippo O., Silvestrini R. Cell proliferation and its relationship to clinical features and relapse in breast cancers. Cancer. 1981 Aug 15;48(4):974–979. doi: 10.1002/1097-0142(19810815)48:4<974::aid-cncr2820480420>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  17. Gerdes J., Becker M. H., Key G., Cattoretti G. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol. 1992 Sep;168(1):85–86. doi: 10.1002/path.1711680114. [DOI] [PubMed] [Google Scholar]
  18. Gerdes J., Lemke H., Baisch H., Wacker H. H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984 Oct;133(4):1710–1715. [PubMed] [Google Scholar]
  19. Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983 Jan 15;31(1):13–20. doi: 10.1002/ijc.2910310104. [DOI] [PubMed] [Google Scholar]
  20. Hall P. A., Crocker J., Watts A., Stansfeld A. G. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Histopathology. 1988 Apr;12(4):373–381. doi: 10.1111/j.1365-2559.1988.tb01952.x. [DOI] [PubMed] [Google Scholar]
  21. Hall P. A., Levison D. A. Review: assessment of cell proliferation in histological material. J Clin Pathol. 1990 Mar;43(3):184–192. doi: 10.1136/jcp.43.3.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hall P. A., Levison D. A., Woods A. L., Yu C. C., Kellock D. B., Watkins J. A., Barnes D. M., Gillett C. E., Camplejohn R., Dover R. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990 Dec;162(4):285–294. doi: 10.1002/path.1711620403. [DOI] [PubMed] [Google Scholar]
  23. Hall P. A., Richards M. A., Gregory W. M., d'Ardenne A. J., Lister T. A., Stansfeld A. G. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol. 1988 Mar;154(3):223–235. doi: 10.1002/path.1711540305. [DOI] [PubMed] [Google Scholar]
  24. Harrison R. F., Reynolds G. M., Rowlands D. C. Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions. J Pathol. 1993 Oct;171(2):115–122. doi: 10.1002/path.1711710208. [DOI] [PubMed] [Google Scholar]
  25. Kempson R. L., Bari W. Uterine sarcomas. Classification, diagnosis, and prognosis. Hum Pathol. 1970 Sep;1(3):331–349. [PubMed] [Google Scholar]
  26. Key G., Petersen J. L., Becker M. H., Duchrow M., Schlüter C., Askaa J., Gerdes J. New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J Clin Pathol. 1993 Dec;46(12):1080–1084. doi: 10.1136/jcp.46.12.1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lynch D. A., Clarke A. M., Jackson P., Axon A. T., Dixon M. F., Quirke P. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol. 1994 Feb;47(2):122–125. doi: 10.1136/jcp.47.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Maddox P. H., Jenkins D. 3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion. J Clin Pathol. 1987 Oct;40(10):1256–1257. doi: 10.1136/jcp.40.10.1256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Malaise E. P., Chavaudra N., Tubiana M. The relationship between growth rate, labelling index and histological type of human solid tumours. Eur J Cancer. 1973 Apr;9(4):305–312. doi: 10.1016/0014-2964(73)90099-6. [DOI] [PubMed] [Google Scholar]
  30. Munakata S., Hendricks J. B. Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J Histochem Cytochem. 1993 Aug;41(8):1241–1246. doi: 10.1177/41.8.8331288. [DOI] [PubMed] [Google Scholar]
  31. Norton A. J. Microwave oven heating for antigen unmasking in routinely processed tissue sections. J Pathol. 1993 Oct;171(2):79–80. doi: 10.1002/path.1711710203. [DOI] [PubMed] [Google Scholar]
  32. Prelich G., Tan C. K., Kostura M., Mathews M. B., So A. G., Downey K. M., Stillman B. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature. 1987 Apr 2;326(6112):517–520. doi: 10.1038/326517a0. [DOI] [PubMed] [Google Scholar]
  33. Quirke P., Dyson J. E. Flow cytometry: methodology and applications in pathology. J Pathol. 1986 Jun;149(2):79–87. doi: 10.1002/path.1711490202. [DOI] [PubMed] [Google Scholar]
  34. Scott N., Cross D., Plumb M. I., Dixon M. F., Quirke P. An investigation of different methods of cell cycle analysis by flow cytometry in rectal cancer. Br J Cancer. 1992 Jan;65(1):8–10. doi: 10.1038/bjc.1992.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Silverberg S. G. Reproducibility of the mitosis count in the histologic diagnosis of smooth muscle tumors of the uterus. Hum Pathol. 1976 Jul;7(4):451–454. doi: 10.1016/s0046-8177(76)80058-5. [DOI] [PubMed] [Google Scholar]
  36. Snead D. R., Bell J. A., Dixon A. R., Nicholson R. I., Elston C. W., Blamey R. W., Ellis I. O. Methodology of immunohistological detection of oestrogen receptor in human breast carcinoma in formalin-fixed, paraffin-embedded tissue: a comparison with frozen section methodology. Histopathology. 1993 Sep;23(3):233–238. doi: 10.1111/j.1365-2559.1993.tb01195.x. [DOI] [PubMed] [Google Scholar]
  37. Thorpe S. M., Rose C., Rasmussen B. B., Mouridsen H. T., Bayer T., Keiding N. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res. 1987 Nov 15;47(22):6126–6133. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES